Type
. Temporal adverse effects in leprosy Saudi patients receiving multi drug. Clinical & Experimental Pharmacology. 2013;4(1).
Type
. Type 1 reaction in leprosy: a model for a better understanding of tissue immunity under an immunopathological condition. Expert review of clinical immunology. 2015;:1-17.
Type
. Psychiatric morbidity among inmates of leprosy homes. Indian Journal of Psychological Medicine. 2013;35(4):335-340.
Type
. Clinical variables associated with leprosy reactions and persistence of physical impairment. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2013;46(5):600-604. Available from: http://www.scielo.br/pdf/rsbmt/v46n5/0037-8682-rsbmt-42-2013.pdf
Type
. Antioxidant factors, nitric oxide levels, and cellular damage in leprosy patients. Revista da Sociedade Brasileira de Medicina Tropical. 2013;46(5):645-649.
Type
. Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy. Memórias do Instituto Oswaldo Cruz [Internet]. 2013;108(7):901-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970646/pdf/0074-0276-mioc-108-07-00901.pdf
Type
. Induction and treatment of anergy in murine leprosy. International journal of experimental pathology [Internet]. 2014;. Available from: http://onlinelibrary.wiley.com/doi/10.1111/iep.12108/epdf
Type
. Sexual and reproductive health and rights services for people affected with leprosy or other disabilities. 2013. p. 28 p.
Type
. Resistance of M. leprae to Quinolones: A Question of Relativity?. PLOS Neglected Tropical Diseases [Internet]. 2013;. Available from: http://www.plosntds.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pntd.0002559&representation=PDF
Type
. Autophagy gene polymorphism is associated with susceptibility to leprosy by affecting inflammatory cytokines. Inflammation. 2013;.